SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-09-105352
Filing Date
2009-05-08
Accepted
2009-05-08 16:06:12
Documents
5
Period of Report
2009-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 390167
2 CERTIFICATION OF PEO PURSUANT TO RULE 13A-14(A) OR RULE 15D-14(A) dex311.htm EX-31.1 5867
3 CERTIFICATION OF PFO PURSUANT TO RULE 13A-14(A) OR RULE 15D-14(A) dex312.htm EX-31.2 5879
4 CERTIFICATION BY THE PEO AND PFO PURSUANT TO RULE 13A-14(B) OR RULE 15D-14(B) dex321.htm EX-32.1 3216
5 GRAPHIC g10189g96h77.jpg GRAPHIC 4460
  Complete submission text file 0001193125-09-105352.txt   412936
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19756 | Film No.: 09810784
SIC: 2836 Biological Products, (No Diagnostic Substances)